Small molecule-switchable RNA platform enables control of therapeutic protein expression

FHS
January 2, 2024
11:27 am

Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.

Opinion | GLP-1s: The Medications Redefining Diabetes and Obesity Treatment

Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is

December 5, 2024

Louisiana legislature approves bill classifying abortion pills as controlled dangerous substances

BATON ROUGE — Two abortion-inducing drugs could soon be reclassified as controlled and dangerous substances in Louisiana under a first-of-its-kind bill that received final legislative

May 23, 2024

Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma 04.12.2023 / 10:00 CET/CEST The issuer is

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.